News und Analysen
DGAP-Adhoc: Delisting der Aktien der HORNBACH Baumarkt AG beabsichtigt; öffentliches Delisting-Erwerbsangebot durch Hauptaktionärin für € 47,50 je Aktie angekündigt; Unterstützung des öffentlichen ...
DGAP-Adhoc: HORNBACH Baumarkt AG intends to delist shares; public delisting offer announced by largest shareholder for € 47.50 per share; HORNBACH Baumarkt AG to support public delisting offer.
DGAP-Adhoc: HORNBACH Holding AG & Co. KGaA: Conclusion of a delisting agreement and unconditional tender offer to the shareholders of HORNBACH Baumarkt AG
DGAP-Adhoc: HORNBACH Holding AG & Co. KGaA: Abschluss einer Delisting-Vereinbarung und unbedingtes Erwerbsangebot an die Aktionäre der HORNBACH Baumarkt AG
U.K. Companies Turning to Intelligent Automation to Solve Business Challenges from Pandemic, Brexit
Many British enterprises have been investing in intelligent business automation even as overall U.K. IT spending declines, according to a new research report published today by Information Services
German Firms Expand Use of Intelligent Automation After Pandemic Shakes Up Ways of Doing Business
German enterprises are increasing their use of intelligent automation, partly in response to disruptions from the COVID-19 pandemic, as the country joins in a European technology and business
Deutsche Unternehmen verstärken den Einsatz intelligenter Automatisierung, um die Folgen der Pandemie zu verarbeiten
Deutsche Unternehmen setzen verstärkt auf intelligente Automatisierung, auch als Reaktion auf die coronabedingten Belastungen ihrer Wertschöpfungsketten, und schließen sich damit dem Boom auf dem
Heidelberger Druckmaschinen AG: Heidelberg und VGP entwickeln modernen HEI-TECH Industriepark am Standort Wiesloch/Walldorf
Heidelberger Druckmaschinen AG: Heidelberg and VGP develop modern HEI-TECH industrial park at Wiesloch/Walldorf site
EQS-News: Neue Direktorin für die Hotelbusiness Zug AG
Ipsen und GENFIT schließen im Rahmen einer langfristigen globalen Partnerschaft eine exklusive Lizenzvereinbarung für Elafibranor ab, ein Phase-III-Asset, das für die Behandlung von primärer biliärer Cholangitis geprüft wird
Disclaimer: Nur für internationale Medien und Investoren bestimmt
Diese Pressemitteilung enthält multimediale Inhalte. Die vollständige Mitteilung hier ansehen: https://www.businesswire.com/news/h
Transgene Announces Investor Meetings for January 2022
Regulatory News:
TRANSGENE (Paris:TNG) today announces that Management will participate in the upcoming investor events set out below.
Transgene will meet institutional investors at the 11th
Form 8.3 - Maitland Institutional Services Limited: Re Clinigen Group Plc NPV
Synalloy Announces Closing of Highly Successful $10 Million Rights Offering
Synalloy Corporation (Nasdaq: SYNL) (“Synalloy” or the “Company”), an industrials company focused on the production and distribution of piping, tubing and specialty chemicals, today announced the
NOW Inc. Amends Senior Secured Revolving Credit Facility
NOW Inc. (NYSE:DNOW) announced today that it has entered into an amendment (the “First Amendment”) to the existing senior secured credit facility with a syndicate of lenders, with Wells Fargo Bank
DGAP-Adhoc: LPKF adjusts full-year guidance for 2021 due to shifts in revenue beyond the year-end reporting date
DGAP-Adhoc: LPKF passt Gesamtjahresprognose 2021 aufgrund von stichtagsbedingten Umsatzverschiebungen an
DGAP-News: INDUS Holding AG: INDUS acquires packaging machinery specialist
DGAP-News: INDUS Holding AG: INDUS erwirbt Spezialisten für Verpackungsmaschinen
Use of Intelligent Automation Expanding in Nordics After Helping Enterprises Meet Pandemic Challenges
The Nordics region is well-positioned for growth in intelligent automation given its overall technological maturity, social trends and rapid economic recovery from a slump triggered by the COVID-19
Ipsen and GENFIT Enter Into Exclusive Licensing Agreement for Elafibranor, a Phase III Asset Evaluated in Primary Biliary Cholangitis, as Part of a Long-Term Global Partnership
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211216006159/en/
Disclaimer: Intended for international media and
DGAP-News: Nordex SE: Nordex Group erhält 110-MW-Auftrag von Statkraft aus Chile
DGAP-News: Nordex SE: The Nordex Group receives 110 MW order from Statkraft in Chile
Navidea Biopharmaceuticals Announces Launch of Phase 3 Clinical Trial in Rheumatoid Arthritis
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today